Intelligent Bio Solutions INC. 8-K Filing
Ticker: INBS · Form: 8-K · Filed: Dec 2, 2025 · CIK: 1725430
Sentiment: neutral
Filing Stats: 503 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-12-02 08:00:52
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 35KB
- ex99-1.htm (EX-99.1) — 19KB
- ex99-1_001.jpg (GRAPHIC) — 301KB
- ex99-1_002.jpg (GRAPHIC) — 348KB
- ex99-1_003.jpg (GRAPHIC) — 181KB
- ex99-1_004.jpg (GRAPHIC) — 210KB
- ex99-1_005.jpg (GRAPHIC) — 308KB
- ex99-1_006.jpg (GRAPHIC) — 210KB
- ex99-1_007.jpg (GRAPHIC) — 262KB
- ex99-1_008.jpg (GRAPHIC) — 178KB
- ex99-1_009.jpg (GRAPHIC) — 239KB
- ex99-1_010.jpg (GRAPHIC) — 290KB
- ex99-1_011.jpg (GRAPHIC) — 400KB
- ex99-1_012.jpg (GRAPHIC) — 193KB
- ex99-1_013.jpg (GRAPHIC) — 343KB
- ex99-1_014.jpg (GRAPHIC) — 204KB
- ex99-1_015.jpg (GRAPHIC) — 243KB
- ex99-1_016.jpg (GRAPHIC) — 239KB
- ex99-1_017.jpg (GRAPHIC) — 371KB
- ex99-1_018.jpg (GRAPHIC) — 359KB
- ex99-1_019.jpg (GRAPHIC) — 295KB
- ex99-1_020.jpg (GRAPHIC) — 163KB
- ex99-1_021.jpg (GRAPHIC) — 177KB
- ex99-1_022.jpg (GRAPHIC) — 113KB
- ex99-1_023.jpg (GRAPHIC) — 201KB
- 0001493152-25-025665.txt ( ) — 8248KB
- inbs-20251202.xsd (EX-101.SCH) — 3KB
- inbs-20251202_lab.xml (EX-101.LAB) — 33KB
- inbs-20251202_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Pursuant to Regulation FD, Intelligent Bio Solutions Inc. (the "Company") hereby furnishes the presentation (the "Presentation") that the Company made available to investors on December 2, 2025, relating to the Company's business and operations. The Presentation can be accessed by visiting the Investors section of the Company's website: www.ibs.inc. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for the purpose of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference. Item 9.01. Financial Statements and Exhibits. No. Description 99.1 Presentation made available on December 2, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 2, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer